Schedule a Demo
<style> /* Global Styles */ .zs-footer__container { padding: 20px; background-color: #F5F5F7; } /* Section A */ .zs-footer__section-a { display: flex; flex-wrap: wrap; al...
The majority of biopharma launches aren't blockbuster products. We take a look at the factors that signal blockbuster potential.
Cell and gene therapy forecasters face unique challenges. To succeed, they must plan for high revenue volatility and alternative payment structures.
Listen to the “Inside Global Pharma” podcast, which covers customer experience in cell and gene therapy as well as the current state of the industry.
Watch this webinar to learn how the next generation of cell and gene therapies will need to deliver new capabilities at a fundamental level.
Watch this webinar by experts from ZS and Salesforce, as they discuss the digital capabilities required to launch cell and gene therapies while ensuring a unique customer experience.
In this webinar, ZS launch and forecasting experts review recent trends with respect to launch performance, as well as highlights from the latest research.
Despite numerous product launches, cell and gene therapy manufacturers are struggling to meet commercial expectations and scale production and commercialization processes.
We partner with you to bring connected solutions to the interconnected and specialized challenges in cell and gene therapy.
